Literature DB >> 24747623

Simultaneous bilateral lengthening of femora and tibiae in achondroplastic patients.

Mehmet Kocaoğlu1, Fikri Erkal Bilen1, Göksel Dikmen2, Halil Ibrahim Balci3, Levent Eralp3.   

Abstract

OBJECTIVE: The aim of this study was to analyze the results and complications of simultaneous bilateral femoral and tibial lengthening in achondroplastic patients.
METHODS: The study included the 44 femora and 44 tibiae of 22 achondroplastic patients (16 females, 6 males; mean age: 6.36 years, range: 3 to 11 years) that underwent simultaneous lengthening. Orthofix LRS monolateral fixators were used for femoral lengthening and either Ilizarov-type or hexapod-type circular external fixators for tibial lengthening. Tenotomies of the hip flexors and the Achilles tendon were performed to prevent injury to the growth plates and to prevent joint contractures. Results and complications were evaluated according to Paley's scoring and complication systems.
RESULTS: Average follow-up time was 35 (range: 26 to 76) months. The femora were lengthened by an average of 7.07 cm (46.1%), and the tibiae by an average of 6.64 cm (52.9%). Patients gained an average of 16.9 cm in height, including physiological growth. The mean bone-healing index (BHI) was 31.2 days/cm for the femora (range: 17.4 to 43.3 days/cm) and 34.3 days/cm for the tibiae (range: 19.5 to 60.0 days/cm). Complications included 3 delayed maturations, 3 pin track infections, 5 transient fibular paralyses, 5 regenerate fractures, 1 late varus deformity, 1 knee contracture and 1 knee contracture secondary to knee dislocation. Functional scores were excellent in 78 segments, good in 8, fair in 1 and poor in one. There was no growth inhibition related to the lengthening.
CONCLUSION: Bilateral simultaneous lengthening of the femora and tibiae in achondroplastic patients provided a reduction in total treatment and external fixation time, with a low rate of complications.

Entities:  

Mesh:

Year:  2014        PMID: 24747623     DOI: 10.3944/AOTT.2014.3274

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  5 in total

Review 1.  Lower extremity growth and deformity.

Authors:  Amanda T Whitaker; Carley Vuillermin
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

Review 2.  Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.

Authors:  Jia Chen; Jiaqi Liu; Yangzhong Zhou; Sen Liu; Gang Liu; Yuzhi Zuo; Zhihong Wu; Nan Wu; Guixing Qiu
Journal:  J Mol Med (Berl)       Date:  2017-10-23       Impact factor: 4.599

3.  Final adult height in long-term growth hormone-treated achondroplasia patients.

Authors:  Daisuke Harada; Noriyuki Namba; Yuki Hanioka; Kaoru Ueyama; Natsuko Sakamoto; Yukako Nakano; Masafumi Izui; Yuiko Nagamatsu; Hiroko Kashiwagi; Miho Yamamuro; Yoshihito Ishiura; Ayako Ogitani; Yoshiki Seino
Journal:  Eur J Pediatr       Date:  2017-05-13       Impact factor: 3.183

4.  Quality of Life Evaluation Following Limb Lengthening Surgery in Patients with Achondroplasia.

Authors:  Sefa Giray Batıbay; Halil İbrahim Balcı; Serkan Bayram; Mehmet Chodza; Şeyda Göksoy; Önder Murat Hürmeydan; Aslı Derya Kardelen; Cengiz Şen; Mehmet Kocaoğlu
Journal:  Indian J Orthop       Date:  2020-05-04       Impact factor: 1.251

5.  Limb lengthening in achondroplasia.

Authors:  Sanjay K Chilbule; Vivek Dutt; Vrisha Madhuri
Journal:  Indian J Orthop       Date:  2016 Jul-Aug       Impact factor: 1.251

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.